Hydralazine Hydrochloride USP 20mg/ml Dealers across India

Description: Taj Pharma India is well known Manufacturer, Exporter and Supplier of Hydralazine Hydrochloride Injection from Vapi, Gujarat India. Hydralazine Hydrochloride Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Taj Pharmaceuticals Ltd, a WHO-GMP and ISO-certified pharmaceutical leader based in Mumbai with modern manufacturing facilities in Vapi, Gujarat, is a prominent manufacturer, exporter, and supplier of Hydralazine Hydrochloride Injection 20mg/ml (Hydrataj). This essential vasodilator is widely used for managing severe hypertension, hypertensive crisis, and acute heart failure, especially in emergency situations where oral medication is not feasible. Hydralazine Hydrochloride Injection works by relaxing and widening blood vessels, improving blood flow, and reducing vascular resistance, leading to rapid blood pressure control—typically within 10–80 minutes of administration. It is administered intravenously or intramuscularly under the supervision of qualified healthcare professionals. The medicine is generally safe for breastfeeding mothers but should be used cautiously during pregnancy. Taj Pharma ensures premium quality through stringent quality checks, adherence to international pharmacopoeial standards, and complete regulatory support including COA, COPP, and stability data. With a strong export network in Africa, the Middle East, LATAM, and Asia, the company also offers PCD Pharma Franchise and third-party manufacturing services. Taj Pharma India is well Known Manufacturer, Distributor and Exporter of Hydralazine Hydrochloride Injection from Vapi, Gujarat India. Hydralazine Hydrochloride 20mg Injection is a potassium channel opener. It works by relaxing blood vessels which lowers blood pressure and allows more blood and oxygen to reach the heart and other organs.

Dimensions: 2560 x 1707

File Type: jpeg

File Size: 295 KB